Apoptin: specific killer of tumor cells?
M Tavassoli1, L Guelen, B A Luxon
1Head and Neck Oncology Group, Department of Oral Medicine and Pathology, King's College London, 123 Coldharbour Lane, London SE5 9NU, UK. mahvash.tavassoli@kcl.ac.uk
Apoptosis : an International Journal on Programmed Cell Death
|September 1, 2005
Summary
Chicken Anemia virus (CAV) protein Apoptin shows promise for cancer therapy by inducing cancer cell death. However, recent studies challenge its tumor-specific action, revealing potential effects on normal cells and creating scientific debate.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- Chicken Anemia virus (CAV) protein VP3/Apoptin exhibits selective cancer cell-killing properties.
- Apoptin's tumor specificity was initially attributed to its nuclear localization in cancer cells versus cytoplasmic localization in normal cells.
- Apoptin induces programmed cell death (PCD) and cell cycle arrest at G2/M, potentially through interaction with the cyclosome.
Purpose of the Study:
- To review and analyze existing data on Apoptin's tumor specificity.
- To address conflicting findings regarding Apoptin's selective action on cancer cells.
- To clarify factors influencing Apoptin's function for potential anti-cancer therapeutic development.
Main Methods:
- Review of published and unpublished in vitro and in vivo studies on Apoptin.
- Analysis of Apoptin's localization, PCD induction, and phosphorylation patterns in normal and tumor cells.
- Evaluation of factors such as protein expression levels and cellular growth rate influencing Apoptin activity.
Main Results:
- Recent studies contradict earlier findings, showing Apoptin can induce PCD in some normal cell lines.
- Evidence suggests high protein expression and cellular growth rate may impact Apoptin's tumor-specific killing ability.
- Controversy exists regarding the "black and white" tumor cell specificity of Apoptin.
Conclusions:
- Apoptin is a potent apoptosis-inducing protein with potential for cancer therapy.
- Further research is needed to understand the factors governing Apoptin's specificity and optimize its therapeutic application.
- Resolving the controversy surrounding Apoptin's tumor specificity is crucial for its development as an anti-cancer agent.
More Related Videos
08:12Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells
Published on: August 11, 2014
09:57Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
Published on: January 29, 2019
Related Concept Videos
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:17Phagocytosis of Apoptotic Cells
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
01:28Cells of the Innate Immune Response
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.